The 36 references in paper A. Chuchalin G., S. Avdeev N., Z. Aisanov R., V. Arkhipov V., A. Belevskii S., N. Nenasheva M., А. Чучалин Г., С. Авдеев Н., З. Айсанов Р., В. Архипов В., А. Белевский С., Н. Ненашева М. (2015) “Согласованные рекомендации по применению антихолинергического препарата длительного действия тиотропия в терапии бронхиальной астмы // Consensus report: indications for use of long-acting antimuscarinic tiotropium in the treatment of bronchial asthma” / spz:neicon:pulmonology:y:2015:i:2:p:143-150

1
Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология. 2011; 6: 87–93. / Arkhipov V.V., Grigor'eva E.V., Gavrishina E.V. Asthma control in Russia: results of the multicenter observational study NIKA. Pul'monologiya. 2011; 6: 87–93 (in Russian).
(check this in PDF content)
2
Braman S.S. The global burden of asthma. Chest.2006; 130 (Suppl. 1 ): 4–12.
(check this in PDF content)
3
Rodrigo G.J., Castro-Rodríguez J.A. What is the role of tiotropium in asthma? A systematic review with metaanalysis. Chest. 2015; 147 (2): 388–396. DOI: 10.1378/ chest.14-1698.
(check this in PDF content)
4
Fardon T., Haggart K., Lee D.K., Lipworth B.J. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir. Med.2007; 101: 1218–1228.
(check this in PDF content)
5
Peters S.P., Kunselman S.J., Icitovic N. еt al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med. 2010; 363 (18): 1715–1726.
(check this in PDF content)
6
Bateman E.D., Kornmann O., Schmidt P. et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J. Allergy Clin. Immunol.2011; 128 (2): 315–322.
(check this in PDF content)
7
Kerstjens H.A., Disse B., Schröder-Babo W. et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J. Allergy Clin. Immunol. 2011; 128 (2): 308–14.
(check this in PDF content)
8
Kerstjens H.A., Engel M., Dahl R. et al. Tiotropium in asthma poorly controlled with standard combination therapy. N. Engl. J. Med.2012; 367 (13): 1198–1207.
(check this in PDF content)
9
http://trials.boehringer-ingelheim.com/trial_results/clinical_ trials_overview/clinical_trial_result.c=i.i=6.html
(check this in PDF content)
10
Vogelberg C., Engel M., Moroni-Zentgraf P. et al. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study. Respir. Med. 2014; 108 (9): 1268–1276.
(check this in PDF content)
11
Beeh K.-M., Moroni-Zentgraf P., Ablinger O. et al. Tiotropium Respimat in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.Respir. Res. 2014; 15: 61.
(check this in PDF content)
12
Kerstjens H.A., Disse B., Schröder-Babo W. et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J. Allergy. Clin. Immunol.2011; 128 (2): 308–314.
(check this in PDF content)
13
Global Strategy for Asthma Management and Prevention. Revised 2014. www.ginasthma.com
(check this in PDF content)
14
Iwamoto H., Yokoyama A., Shiota N. et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur. Respir. J. 2008; 31: 1379–1382. ** Недостаточный контроль симптомов – наличие за последние 4 нед. минимум одного из признаков: дневные симптомы чаще 2 раз в неделю, использование бронхолитических препаратов по потребности чаще 2 раз в неделю, минимум 1 пробуждение ночью из-за БА, любые ограничения активности из-за БА (GINA, 2014).
(check this in PDF content)
15
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Revised 2014. www.goldcopd.com
(check this in PDF content)
16
Marco R., Pesce G., Marcon A. et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): Prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS ONE. 2013; 8 (5): e62985. DOI:10.1371/journal.pone.0062985.
(check this in PDF content)
17
Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS).http:// www.ginasthma.org
(check this in PDF content)
18
Soler-Cataluña J.J., Cosío B., Izquierdo J.L. Consensus document on the overlap phenotype COPD – asthma in COPD.Arch. Bronconeumol. 2012; 48 (9): 331–337.
(check this in PDF content)
19
Magnussen H., Bugnas B., van Noord J. et al. Improvements with tiotropium in COPD patients with concomitant asthma. Respir. Med.2008; 102: 50–56.
(check this in PDF content)
20
Magnussen H., Bugnas B., van Noord J. et al. COPD and concomitant asthma: Efficacy of tiotropium in different age, PEFR variability and bronchodilator responsiveness groupings. ATS International Conference; 2008: Abs. 649.
(check this in PDF content)
21
Yoshida M., Nakano T., Fukuyama S. et al. Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes. Pulm. Pharmacol. Ther. 2013; 26: 159–166.
(check this in PDF content)
22
Catterall J.R., Rhind G.B., Whyte K.F. et al. Is nocturnal asthma caused by changes in airway cholinergic activity? Thorax. 1988; 43: 720–724.
(check this in PDF content)
23
Coe C.I., Barnes P.J. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest. 1986; 90: 485–488.
(check this in PDF content)
24
Cox I.D., Hughes D.T., McDonnell K.A. Ipratropium bromide in patients with nocturnal asthma. Postgrad Med. J. 1984; 60: 526–528.
(check this in PDF content)
25
McNicholas W.T., Calverley P.M.A., Lee A. et al. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD.Eur. Respir. J.2004; 23: 825–831.
(check this in PDF content)
26
Di Lorenzo G., Mansueto P., Ditta V. et al. Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease. Respir. Med.2008; 102 (2): 232–238.
(check this in PDF content)
27
Peters S.P., Bleecker E.R., Kunselman S.J. et al. Predictors of response to tiotropium versus salmeterol in asthmatic adults.J. Allergy Clin. Immunol.2013; 132 (5): 1068–1074.
(check this in PDF content)
28
ten Brinke A., Zwinderman A.H., Sterk P.J. et al. Factors associated with persistent airflow limitation in severe asthma. Am. J. Respir. Crit. Care Med.2001; 164: 744–748.
(check this in PDF content)
29
Busacker A., Newell J.D. Jr., Keefe T. et al. A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest. 2009; 135: 48–56.
(check this in PDF content)
30
O'Donnell D.E., Fluge T., Gerken F. et al. Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD.Eur. Respir. J. 2004; 23: 832–840.
(check this in PDF content)
31
Bedard M.E., Brouillard C., Pepin V. et al. Tiotropium improves walking endurance in COPD.Eur. Respir. J. 2012; 39: 265–271.
(check this in PDF content)
32
Feschenko Y., Yashyna L., Gorovenko N. et al. Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma. Eur. Respir. J. 2007; 30 (Suppl.): 553–554.
(check this in PDF content)
33
Miota J., Barbara C., Cardoso J. et al. Tiotropium improves FEV1in patients with COPD irrespective of smoking status. Pulm. Pharmacol. Ther. 2008; 21 (1): 146–151.
(check this in PDF content)
34
Ahmad Z., Singh S.K. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics.J. Asthma.2010; 47 (3): 340–343.
(check this in PDF content)
35
Rebordosa C., Kogevinas M., Guerra S. et al. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. Eur. Respir. J. 2011; 38 (5): 1029–1035.
(check this in PDF content)
36
Park H.W., Yang M.S., Park C.S. et al. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy. 2009; 64: 778–783. Поступила 27.05.15
(check this in PDF content)